Cycle economics, measured properly.
IVF revenue is not per visit — it is per cycle, often paid in stages, after a long consultation-to-decision gap and expensive acquisition. Drapto measures revenue at cycle level, tracks staged payments as they age, and shows what a started cycle actually costs to win.
The screen
54
₹2,40,000
11
₹38,60,000
₹2.4LDrugs issued from stock, not charged21 patients
11Cycle stage overdue, patient not calledschedule
7Package quoted, procedure billed separatelyreconcile
4Consent for the stage not recordedcollect
43On protocol, on schedule, billedclean
Long protocols, expensive drugs and a patient paying most of it themselves. A missed charge here is not a rounding error.
it actually accrues
tracked by age
started, tracked
against cycles, not leads
One lost cycle costs more than a month of consultations.
Fertility economics concentrate enormous value into a small number of decisions. A consultation that never converts, or a package instalment that quietly ages past ninety days, matters far more here than in almost any other speciality.
Revenue at cycle level, not visit level
Consultations, investigations, procedures and the cycle itself all carry different economics. Drapto reports revenue by treatment and by clinician so you can see which parts of the pathway carry the centre and which are effectively loss leaders.
- Revenue by treatment type across the pathway
- Contribution by consultant and by centre
- Period comparison to separate seasonality from trend
- Multi-branch comparison on identical definitions
Staged payments that age like any other balance
Package and instalment structures mean substantial sums sit outstanding for months by design. The risk is that genuine arrears look identical to scheduled instalments until someone checks. Ageing buckets separate the two.
- 0–30 / 31–60 / 61–90 / 90+ ageing on outstanding balances
- Recovery tracked across partial and staged payments
- Collection efficiency by centre and by consultant
- Historical ledgers retained for audit and review
What a started cycle actually costs to win
Fertility acquisition is expensive and the decision window is long. Measuring channels on enquiries is close to meaningless here — the only number that matters is cost per cycle started, by channel and campaign.
- Channel ROI tied to actual invoices, not enquiries
- Cost per patient acquired by channel and campaign
- Consultation-to-cycle conversion funnels
- Referring clinicians measured alongside digital channels
What changes for your team.
Pathway economics become visible
You can see which parts of the pathway carry margin and which quietly subsidise the rest.
Arrears separate from schedule
Ageing distinguishes a genuinely overdue instalment from one that is simply not due yet.
Acquisition spend gets judged correctly
Cost per cycle started is the honest number, and it frequently reorders which channels look worthwhile.
Consultant contribution is contextual
Ranking within the centre rather than across specialities keeps performance conversations fair.
Straight answers.
Does Drapto handle cycle clinical records?
No. Clinical and embryology records stay in your existing systems. Drapto is the revenue and operational measurement layer above them.
Can it handle package and instalment payments?
Yes. Partial and staged payments are tracked against the original balance, with ageing applied so overdue amounts are distinguishable from scheduled ones.
Can we measure consultation-to-cycle conversion?
Yes, through lead-to-patient conversion funnels, which is the metric that matters most in fertility marketing.
Do the AI agents work for this speciality?
Yes. All three agents run on your own AI provider key and work from data already in your account. The Revenue Leakage Analyst calculates deterministically, so every figure it reports is verifiable against your own books.
Measure the cycle, not just the visit.
Built to standards, not to a demo
Corporate contracts, without changing your system.
We find the companies and run the outreach. Your existing software stays where it is.